Search research articles
Contact Us
Filters
Showing results (641-650 of 656) with videos related to
Page
of 66
Sort By:
Journal of Medicinal Chemistry
|
July 18, 2013
Toxoflavins and deazaflavins as the first reported selective small molecule inhibitors of tyrosyl-DNA phosphodiesterase II
Ali Raoof, Paul Depledge, Niall M Hamilton, et al.
Nature Communications
|
October 2, 2019
High levels of AAV vector integration into CRISPR-induced DNA breaks
Killian S Hanlon, Benjamin P Kleinstiver, Sara P Garcia, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 13, 2025
Extracellular vesicles-associated AAVs for the treatment of Machado-Joseph disease
Carina Henriques, Patrícia Albuquerque, David Rufino-Ramos, et al.
Frontiers in Immunology
|
October 21, 2022
Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults
Srabanti Rakshit, Vasista Adiga, Asma Ahmed, et al.
Blood
|
November 17, 2020
EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity
M K Gandhi, T Hoang, S C Law, et al.
Cell Metabolism
|
February 17, 2021
Creatine-mediated crosstalk between adipocytes and cancer cells regulates obesity-driven breast cancer
Olivia A Maguire, Sarah E Ackerman, Sarah K Szwed, et al.
European Journal of Medicinal Chemistry
|
February 15, 2016
The discovery of 2-substituted phenol quinazolines as potent RET kinase inhibitors with improved KDR selectivity
Rebecca Newton, Katherine A Bowler, Emily M Burns, et al.
The Journal of Infection
|
October 17, 2020
Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England
Philippa M Wells, Katie J Doores, Simon Couvreur, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 15, 2021
Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections
Liane Dupont, Luke B Snell, Carl Graham, et al.
Nature Microbiology
|
October 16, 2021
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
Liane Dupont, Luke B Snell, Carl Graham, et al.
Page
of 66
Search research articles
Search
Showing results (641-650 of 656) with videos related to
Sort By:
Page
of 66
Journal of Medicinal Chemistry
|
July 18, 2013
Toxoflavins and deazaflavins as the first reported selective small molecule inhibitors of tyrosyl-DNA phosphodiesterase II
Ali Raoof, Paul Depledge, Niall M Hamilton, et al.
Nature Communications
|
October 2, 2019
High levels of AAV vector integration into CRISPR-induced DNA breaks
Killian S Hanlon, Benjamin P Kleinstiver, Sara P Garcia, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 13, 2025
Extracellular vesicles-associated AAVs for the treatment of Machado-Joseph disease
Carina Henriques, Patrícia Albuquerque, David Rufino-Ramos, et al.
Frontiers in Immunology
|
October 21, 2022
Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults
Srabanti Rakshit, Vasista Adiga, Asma Ahmed, et al.
Blood
|
November 17, 2020
EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity
M K Gandhi, T Hoang, S C Law, et al.
Cell Metabolism
|
February 17, 2021
Creatine-mediated crosstalk between adipocytes and cancer cells regulates obesity-driven breast cancer
Olivia A Maguire, Sarah E Ackerman, Sarah K Szwed, et al.
European Journal of Medicinal Chemistry
|
February 15, 2016
The discovery of 2-substituted phenol quinazolines as potent RET kinase inhibitors with improved KDR selectivity
Rebecca Newton, Katherine A Bowler, Emily M Burns, et al.
The Journal of Infection
|
October 17, 2020
Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England
Philippa M Wells, Katie J Doores, Simon Couvreur, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 15, 2021
Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections
Liane Dupont, Luke B Snell, Carl Graham, et al.
Nature Microbiology
|
October 16, 2021
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
Liane Dupont, Luke B Snell, Carl Graham, et al.
Page
of 66